Concepedia

Publication | Open Access

Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis

DOIFull Paper Access

347

Citations

28

References

2012

Year

Steven Boonen, Jean‐Yves Reginster, Jean‐Marc Kaufman, Kurt Lippuner, José Zanchetta, Bente Langdahl, René Rizzoli, Stanley Lipschitz, Hans Peter Dimai, Richard Witvrouw,
New England Journal of Medicine

Abstract

Zoledronic acid treatment was associated with a significantly reduced risk of vertebral fracture among men with osteoporosis. (Funded by Novartis Pharma; ClinicalTrials.gov number, NCT00439647.).

References

YearCitations

Page 1